Abstract Because of its control of spike-timing and oscillatory network activity, γ-aminobutyric acid (GABA)-ergic inhibition is a key element in the central regulation of somatic and mental functions. The recognition of GABA A receptor diversity has provided molecular tags for the analysis of distinct neuronal networks in the control of specific pharmacological and physiological brain functions. Neurons expressing α 1 GABA A receptors have been found to mediate sedation, whereas those expressing α 2 GABA A receptors mediate anxiolysis. Furthermore, associative temporal and spatial memory can be regulated by modulating the activity of hippocampal pyramidal cells via extrasynaptic α 5 GABA A receptors. In addition, neurons expressing α 3 GABA A receptors are instrumental in the processing of sensory motor information related to a schizophrenia endophenotype. Finally, during the postnatal development of the brain, the maturation of GABAergic interneurons seems to provide the trigger for the experience-dependent plasticity of neurons in the visual cortex, with α 1 GABA A receptors setting the time of onset of a critical period of plasticity. Thus, particular neuronal networks defined by respective GABA A receptor subtypes can now be linked to the regulation of various clearly defined behavioural patterns. These achievements are of obvious relevance for the pharmacotherapy of certain brain disorders, in particular sleep dysfunctions, anxiety disorders, schizophrenia and diseases associated with memory deficits.
the soma of hippocampal pyramidal cells is innervated by two types of basket cells: the fast spiking parvalbumincontaining basket cells form synapses containing α 1 GABA A receptors, which display fast kinetics of deactivation (Nyíri et al. 2001; Klausberger et al. 2002; Freund and Buzsaki 1996; Pawelzik et al. 2002) , whereas the synapses of the regular spiking cholecystokinin (CCK)-positive basket cells contain α 2 GABA A receptors, which display slower kinetics than α 1 receptors (Nyíri et al. 2001; Brussaard and Herbison 2000; Hutcheon et al. 2000; Jüttner et al. 2001; Vicini et al. 2001) . Axon initial segments of principal cells also contain α 2 receptors, which appear to be kinetically sufficient for simple on/off signalling. Furthermore, distinct GABA A receptors are segregated to synaptic and extrasynaptic membranes (Nusser et al. 1998; Fritschy and Brünig 2003) . Thus, functionally specialized interneurons operate with the kinetically appropriate GABA A receptor subtypes to regulate network behaviour ( Fig. 1 , Table 1 ). Since GABAergic interneurons are operative throughout the brain, a highly diverse repertoire of GABA A receptors is required.
Retrograde regulation of GABAergic interneurons
Retrograde signalling adds another level of complexity to the regulation of interneuron activity. The terminals of CCK-positive GABAergic basket cells in hippocampus and amygdala contain CB1-cannabinoid receptors (Katona et al. 1999 (Katona et al. , 2001 ). These receptors mediate depolarisationinduced suppression of inhibition (DSI) (Pitler and Alger 1994; Alger and Pitler 1995) . This phenomenon is due to endocannabinoids which emanate from the postsynaptic cell and act as retrograde signal (Wilson and Nicoll 2001; Maejima et al. 2001) . The depolarization of hippocampal pyramidal cells (Pitler and Alger, 1992) and of cerebellar Purkinje cells (Llano et al. 1991) results in a transient decrease in the release of GABA from inhibitory terminals that contain CB1-receptors and synapse onto the depolarized cells (Vincent and Marty, 1993; Pitler and Alger, 1994; Alger and Pitler, 1995) .Both the DSI in the hippocampus (Wilson and Nicoll 2001; Maejima et al. 2001 ) and the cerebellum (Kreitzer and Regehr 2001a,b) are the result of activity-dependent de-novo synthesis and release of endo- Representation of a GABAergic synapse depicting major elements of signal transduction. GABA A receptors are heteromeric membrane proteins linked by an as yet unknown mechanism to the synaptic anchoring protein, gephyrin, and the cytoskeleton. The sequence of subunits corresponds to a modelling proposal (Ernst et al. 2003) . The binding sites for GABA and benzodiazepines are located at the interface of the α/β and α/γ 2 subunits, respectively.
Synaptic GABA A receptors mediate phasic inhibition providing a rapid point-to-point communication for synaptic integration and control of rhythmic network activities. Extrasynaptic GABA A receptors (not shown) are activated by synaptic spillover or the nonvesicular release of GABA. By mediating tonic inhibition, they provide a maintenance level of reduction in neuronal excitability (Mody and Pearce 2004; Möhler et al. 2005) cannabinoids from the postsynaptic neuron. By interacting with CB1 receptors, the calcium influx into the presynaptic terminal is reduced (Kreitzer and Regehr 2001a; Caulfield and Brown 1992) resulting in a decrease of GABA release. Pharmacologically, the inhibition of the degradation of anandamide resulted in an CB1 receptor-mediated anxiolytic response (Kathuria et al. 2003) . Recently, endocannabinoids were shown to mediate not only transient, but also long term changes in inhibitory synaptic transmission. Endocannabinoid production, stimulated through metabotropic glutamate receptor activation in hippocampal pyramidal cells, caused a long lasting reduction in GABAergic signaling onto the pyramidal cells (Chevaleyre and Castillo 2003) . A similar change in long-term synaptic plasticity of the GABAergic system was observed in the amygdala. The release of endocannabinoids in the basolateral amygdala contributed to the extinction of aversive memory based on a long lasting decrease of GABAergic signalling (Marsicano et al. 2002) . Thus, CB1 receptor activation in the hippocampus, amygdala and possibly other parts of the brain result in reduced levels of anxiety. This is due to either a transient depression of GABA release or a modulation of long term plasticity at the respective synapses. In addition, endocannabinoids act as retrograde signals at excitatory glutamatergic synapses where they mediate a depolarisation-induced suppression of excitation (Kreitzer and Regehr 2001a) which may also contribute to their behavioral effects.
Structure of GABA A receptors
Like other members of the nicotinic superfamily of ligand-gated ion channels, ionotropic GABA receptors are considered to consist of 5 protein subunits arranged around a central pore that constitutes the actual ion channel. Each subunit has a large extracellular N-terminal domain which incorporates part of the agonist/antagonist binding site, followed by three membrane spanning domains (M1-3), an intracellular loop of variable length and a fourth membrane spanning domain (M4), with the C-terminal end being extracellular. Each subunit arranges itself such that the second membrane-spanning domain (M2) forms the wall of the channel pore. The cytoplasmic loop, between the third and fourth transmembrane domains (M3 and M4), is believed to be the target for protein kinases, required for subcellular targeting and membrane clustering of the receptor. There are 16 different subunits comprising the GABA A receptor family: α 1-6 , β 1-3 , γ 1-3 , δ, ɛ, π and θ. In addition, there are splice variants of many of these subunits. Based on this subunit repertoire more than 2000 different GABA A receptors could exist if the subunit combinations were restricted to those containing two α, two β and one other subunit. In fact, studies of native GABA A receptors suggest that there may be less than 20 widely occurring GABA A receptor subtype combinations, with the major combinations being α 1 β 2/3 γ 2 , α 2 β 3 γ 2 , α 3 β 3 γ 2 (for review Barnard et al. 1998; Whiting et al. 2000; Sieghart and Sperk 2002; Möhler et al. 2000 Möhler et al. , 2002 Möhler et al. , 2005 Möhler 2001 Möhler , 2002 Fritschy et al. 2004; Rudolph and Möhler 2006) (Table 1 ).
In the retina homomeric receptors consisting of the ρ subunit represent a particular class of GABA gated chloride channels. Their GABA site is insensitive to bicuculline and baclofen and they are not modulated by barbiturates or benzodiazepines. Due to these distinctive features the receptors are sometimes termed GABA c -receptors (Bormann 2000) , although they are a homomeric class of GABA A -receptors (Barnard et al. 1998) .
The physiological significance of the structural diversity of GABA A receptors lies in the provision functionally diverse of receptors which differ in their channel kinetics, affinity for GABA, rate of desensitization and ability for transient chemical modification such as phosphorylation. In addition, GABA A receptor subtypes differ in their topology in neuronal networks in that they show a cell-type specific expression and-in case of multiple receptor subtypes present in a neuron-a domain-specific location (Table 1) .
Pharmacology of GABA A receptors
Diazepam-sensitive GABA A receptors Receptors containing the α 1 , α 2 , α 3 or α 5 subunits in combination with any of the β subunits and the γ 2 subunit are most prevalent in the brain. These receptors are sensitive to benzodiazepine modulation. The major receptor subtype is assembled from the subunits α 1 β 2 γ 2 , with only a few brain regions lacking this receptor (e.g. granule cell layer of the olfactory bulb, reticular nucleus of the thalamus, spinal cord motoneurons) (Fritschy and Mohler 1995; Pirker et al. 2000, Fritschy and Brünig 2003) .
Receptors containing the α 2 or α 3 subunit are considerably less abundant and are highly expressed in brain areas where the α 1 subunit is absent or present at low levels. The α 2 and α 3 subunits are frequently coexpressed with the β 3 and γ 2 subunits which is particularly evident in hippocampal pyramidal neurons (α 2 β 3 γ 2 ) and in cholinergic neurons of the basal forebrain (α 3 β 3 γ 2 ). The α 3 GABA A receptors are the main subtypes expressed in monoaminergic and basal forebrain cholinergic cells (Gao et al. 1993) and are, in addition, strategically located in the thalamic reticular nucleus for modulating the thalamo-cortical circuit (Huntsmann et al. 1999 ). Marked differences in desensitization kinetics have been reported between synaptic α 2 -and extrasynaptic α 3 -receptors whereby the latter desensitize very slowly (Devor et al. 2001 ). The factors regulating GABA A receptor kinetics at synaptic and extrasynaptic sites are yet unknown (Moss and Smart 2001) . The ligandbinding profile of the α 2 -and α 3 -receptors differs from that of α 1 β 2 γ 2 by having a considerably lower displacing potency for ligands such as βCCM, CL 218,872, and zolpidem.
Receptors containing the α 5 subunit are of minor abundance in the brain but are expressed to a significant extent in the hippocampus, where they comprise 15 % to 20 % of the diazepam-sensitive GABA A receptor population, predominately coassembled with the β 3 and γ 2 subunits. Pharmacologically, the α 5 -receptors are differentiated from α 1 β 2 γ 2 , α 2 β 3 γ 2 and α 3 β 3 γ 2 receptors by a lower affinity to CL 218, 872 and near-insensitivity to zolpidem.
The subunits γ 1 and γ 3 characterize a small population of receptors that contain various types of α and β subunits. Due to their reduced affinity for the classical benzodiazepines they do not appear to contribute to any great extent to their pharmacology in vivo.
It should be kept in mind that complex benzodiazepine actions such as the development of tolerance can implicate more than a single receptor subtype. For instance, while the sedative action of diazepam is mediated by α1 GABA A receptors (see below), the development of tolerance to this action under chronic diazepam treatment requires the interaction with both α1 GABA A receptors and α5 GABA A receptors (van Rijnsoever et al. 2004 ).
Diazepam-insensitive GABA A receptors GABA A receptors that do not respond to clinically used ligands such as diazepam, flunitrazepam, clonazepam, and zolpidem are of low abundance in the brain and are largely characterized by the α 4 and α 6 subunits. Receptors containing the α 4 subunit are generally expressed at very low abundance but more prominently in thalamus and dentate gyrus (Pirker et al. 2000) ; those containing the α 6 subunit are restricted to the granule cell layer of the cerebellum (about 30-50 % of all GABA A receptors in the cerebellum; Nusser et al. 1996; Pöltl et al. 2003) . Both receptor populations are structurally heterogeneous, and the majority of the α 6 -containing receptors contain the γ 2 subunit in the α 6 α 1 β 2 γ 2 subunit combination (Pöltl et al. 2003) . Apart form the lack of affinity of classical benzodiazepines, the benzodiazepine-site profile of α 4 and α 6 receptors is characterized by a low affinity for flumazenil and bretazenil and an agonistic efficacy of Ro 15-4513 and bretazenil (Benson et al. 1998) . The δ subunit is frequently coassembled with the α 4 or the α 6 subunit in benzodiazepine insensitive receptors Whiting et al. 2000; Möhler 2001 ). Receptors containing the δ subunit are located exclusively at extrasynaptic sites as shown in dentate gyrus and cerebellum. They are tailor made for tonic inhibition, due to their high affinity for GABA and slow desensitization kinetics (Brickley et al. 1996 (Brickley et al. , 2001 ).
GABA A receptor subtypes: a new pharmacology
The selective pattern of expression of GABA A receptor subtypes opened the possibility to modulate distinct neuronal circuits, provided novel ligands were found which displayed a differential interaction with GABA A receptor subtypes based on either selective affinity or selective efficacy (Table 2) . Such agents would be expected to display therapeutic indications which are more selective than those of the classical benzodiazepines and go beyond their spectrum of activity.
The dissection of receptor pharmacology has been achieved experimentally by generating four lines of pointmutated mice in which the receptors containing the α 1 , α 2 , α 3 or α 5 subunits, respectively, are rendered diazepaminsensitive by replacing a conserved histidine residue (H) in the drug-binding domain by an arginine (R; Benson et al. 1998; Rudolph et al. 1999; Löw et al. 2000; Crestani et al. 2002) . In the respective point-mutated mice, the pharmacological action linked to the point-mutated receptor should be missing and thereby reveal the pharmacological relevance of the respective receptor in wild-type mice. Since the subunit composition and distribution of GABA A receptor subtypes are largely conserved between rodents and non-human primates, the results are thought to be relevant to the human condition .
GABA A receptors for sedation and sleep
Frequently, sedation is taken as a surrogate marker for hypnotic activity. The sedative component of benzodiazepines, measured by the reduction of locomotor activity, has been attributed to neuronal circuits expressing α 1 GABA A receptors, the most prevalent receptor subtype in the brain. Mice in which the α 1 GABA A receptor has been rendered diazepam-insensitive by a point mutation [α 1 (H101R)] fail to be sedated by diazepam (Rudolph et al. 1999; McKernan et al. 2000) . Ligands with a preferential affinity for α 1 receptors such as zolpidem or zaleplon are used as hypnotics (Table 2) . Similarly, the changes in the electroencephalogram (EEG) pattern induced by zolpidem in wildtype mice are almost exclusively mediated via α 1 GABA A receptors (Kopp et al. 2004a ). However, the changes in sleep architecture (suppression of rapid eye movement or REM sleep) and EEG-frequency profiles (reduction of slow-wave sleep, increase in fast β-frequencies) induced by classical benzodiazepines are largely attributable to effects mediated by receptors others than α 1 (Tobler et al. 2001) . The enhancement of α 2 GABA A receptors by diazepam appears to have the most pronounced effect on the sleep EEG in wild-type mice. When the α 2 GABA A receptor is rendered diazepam-insensitive by a point mutation [α 2 (H101R)], the diazepam-induced suppression of δ-waves, the increase in fast β-waves in non-REM sleep (>16 Hz) and the diazepam-induced increase of θ-waves in REM sleep are strongly attenuated (Kopp et al. 2004b ). Thus, the hypnotic EEG fingerprint of diazepam can be dissociated from its sedative action. Future hypnotics might target changes in the EEG pattern, which are characteristic of physiological sleep, and thereby aim at improving sleep quality. For instance, the GABA-mimetic gaboxadol (4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridine-3-0l hydrochlo-ride; synonym THIP), which interacts preferentially with α 4 β 3 δ GABA A receptors in vitro (Brown et al. 2002; Storustovu and Ebert 2003) has been found to enhance slow-wave sleep in vivo (Lancel and Steiger 1999; Huckle 2004) .
GABA A receptors for anxiolytic action
Since α 1 GABA A receptors were found to mediate sedation but not anxiolysis (Rudolph et al. 1999; McKernan et al. 2000) , the anxiolytic activity of benzodiazepines was expected to reside in one or several of the remaining benzodiazepine-sensitive GABA A receptors (α 2 , α 3 , α 5 ). The differentiation of GABA A receptors by knock-in point mutations showed that the α 2 receptor, but not the α 3 or α 5 GABA A receptor, mediated the anxiolytic activity of diazepam (Löw et al. 2000; Crestani et al. 2002) . In α 2 (H101R) mice, but not in α 3 (H126R) or α 5 (H105R) mice, diazepam failed to induce anxiolytic activity (lightdark paradigm, elevated plus maze). With respect to the α 2 GABA A receptor, a highly selective target for the anxiolytic activity of benzodiazepine tranquillizers had Rudolph and Möhler (2006) 1 Classical partial agonists that do not differentiate between GABA A receptor subtypes such as Bretazenil (Haefely et al. 1990) or Pagoclone (Atack et al. 2006b ) are not considered in this review. 2 Data should be treated with caution as properties of recombinant receptors that are expressed in foreign host cells might not give an accurate reflection of their neuronal counterparts. 3 GABA is a weak partial agonist on δ-containing receptors, which largely explains the strong modulatory response of ligands acting on δ-containing receptors (Bianchi and MacDonald 2003) . THDOC, been identified. In keeping with this notion, the benzodiazepine site ligand L-838417, which exhibited efficacy at α 2 , α 3 and α 5 but not α 1 GABA A receptors, proved to be anxiolytic in wild-type rats (Table 2 ; McKernan et al. 2000) . Similarly, partial agonists of 3-heteroaryl-2-pyridones acting at the benzodiazepine site with efficacy at α 2 , α 3 and α 5 receptors, but not at α 1 receptors, were found to show anxiolytic activity in rodents (Table 2 ; Collins et al. 2002) . Nevertheless, the extent to which the α 3 GABA A receptor component contributed to the anxiolytic activity of these ligands remained to be clarified. In mice that lacked α 3 GABA A receptors, the anxiolytic activity of diazepam was undiminished . However, an α 3 -selective inverse agonist was anxiogenic and proconvulsant in rodents (Table 2 ; Collins et al. 2002) . In addition, TP003 with selective efficacy at the α 3 GABA A receptor was anxiolytic, although only at high receptor occupancy (Dias et al. 2005) . Classical benzodiazepines exert anxiolysis at low receptor occupancy suggesting that the α 2 GABA A receptors, and not the α 3 GABA A receptors, are the major mediators of this activity. The contribution of α 3 GABA A receptors is unlikely to be of major relevance. Thus, the strategy to develop novel daytime anxiolytics, which are free of sedation, is clear (Whiting 2003; Möhler et al. 2002; Möhler et al. 2005 ). The α 2 GABA A receptors by their preponderant localization on the axon-initial segment of principal cells in the cerebral cortex and hippocampus can control the output of these cells. In addition, among α 1 , α 2 and α 3 GABA A receptors, α 2 receptors are prominent in the central nucleus of the amygdala, a key area for the control of emotions, whereas α 1 GABA A receptors are totally absent (Marowsky et al. 2004) . Thus, by their strategic distribution in brain areas involved in anxiety responses, α 2 GABA A receptors represent key substrates for anxiolytic drug action.
GABA A receptors for learning and memory
Hippocampal pyramidal cells express various structurally diverse GABA A receptors in a domain-specific manner. Whereas α 1 and α 2 GABA A receptors are largely synaptic, α 5 GABA A receptors are located extrasynaptically at the base of the spines and on the adjacent shaft of the pyramidal cell dendrite. The α 5 GABA A receptors are therefore in a privileged position to modulate the excitatory input arising at the spines via N-methyl-D-aspartate (NMDA) receptors. The introduction of a point mutation (H105R) into the α 5 subunit is associated with a specific reduction of the hippocampal α 5 -subunit-containing GABA A receptors, whereas the pattern of distribution is undisturbed (Crestani et al. 2002) . Mice with a partial deficit of α 5 GABA A receptors in the hippocampus show an improved performance in trace fear conditioning, a hippocampus-dependent memory task (Crestani et al. 2002) . In addition, these mutants display a resistance to the extinction of conditional fear over several days (Yee et al. 2004) . Similarly, in a mouse line in which α 5 GABA A receptors are absent in the entire brain (Collinson et al. 2002; Whiting 2003) , improved performance has been observed in the water maze model of spatial learning. Furthermore, a partial inverse agonist acting at α 5 GABA A receptors enhances the performance of wild-type rats in the water maze test (Chambers et al. 2003 ; Table 2 ). Thus, neuronal inhibition in the hippocampus mediated via α 5 GABA A receptors is a critical element in the regulation of the acquisition and expression of associative memory. Of note, the behavioural consequences of an impairment of α 5 GABA A receptors are opposite to those of an NMDA receptor deficit as shown in spatial and temporal associative memory tasks. Thus, these two receptor systems seem to play a complementary role in controlling signal transduction at the hippocampal principal cells.
GABA A receptors for sensorimotor processing
A deficit in GABAergic inhibitory control is one of the major hypothesis underlying the symptomatology of schizophrenia (Lewis et al. 2005) . A potential contribution of GABA A receptor subtypes has therefore been investigated with regard to the overactivity of the dopaminergic system, an overactivity considered to be a major factor in schizophrenia. The dopaminergic system is under GABAergic inhibitory control mainly via α 3 -containing GABA A receptors (Fritschy and Möhler 1995; Pirker et al. 2000) . Their functional role has been explored in mice lacking the α 3 subunit gene. Mice with an α 3 -knockout display no adaptive changes in the expression of α 1 , α 2 and α 5 subunits and their anxiety-related behaviour is normal. However, they exhibit a marked deficit in prepulse inhibition of the acoustic startle reflex, pointing to a deficit in sensorimotor information processing . This deficit in prepulse inhibition is normalized by the administration of the antipsychotic dopamine D2-receptor antagonist haloperidol, suggesting that the behavioural phenotype is caused by hyperdopaminergia ). Attenuation of prepulse inhibition is a frequent phenotype of psychiatric conditions, including schizophrenia. These results suggest that α 3 -selective agonists might constitute an effective treatment for sensorimotor gating deficits in various psychiatric conditions, a view supported by the observation that the partial benzodiazepine-site agonist bretazenil, in earlier open clinical trials, displayed an antipsychotic activity similar to neuroleptic drugs (DeliniStula and Berdah Tordjman 1996) . The α 3 -selective agonists might lack the sedative or extrapyramidal side-effects of classical neuroleptics and would thus be valuable agents.
Among various brain structures, the hippocampus is believed to play an important role in the modulation of prepulse inhibition. In α 5 (H105R) point-mutated mice, the expression of the α 5 subunit containing GABA A receptors in the hippocampus is reduced (see above; Crestani et al. 2002) . In these animals, prepulse inhibition is attenuated concomitant with an increase in spontaneous locomotor activity (Hauser et al. 2005) . Thus, the α 5 -subunit-containing GABA A receptors, which are located extrasynaptically and are thought to mediate tonic inhibition, are important regulators of the expression of prepulse inhibition and locomotor exploration. Post-mortem analyses of brains from patients with schizophrenia have consistently revealed structural abnormalities of developmental origin in the hippocampus (Lewis et al. 2005) . Such abnormalities may include disturbances of α 5 GABA A receptor function given that schizophrenic patients are known to exhibit a deficit in prepulse inhibition. Thus, agonists acting on both α 3 and α 5 GABA A receptors may be beneficial in overcoming this endophenotypic manifestation of the disease.
GABA A receptors for anaesthetic action
The targets that mediate the clinical effects of general anaesthetics are largely unknown (Campagna et al. 2003; Rudolph and Antkowiak 2004) . Recent work has focused on the role of GABA A receptors, with studies being based on the analysis of point-mutated knock-in mice carrying point mutations in the β 3 and β 2 subunits of the GABA A receptor. These mutations render the GABA A receptors containing the respective subunits insensitive to modulation by etomidate, propofol and certain volatile anaesthetics, such as enflurane. The β 3 -containing GABA A receptors have been found to mediate the immobilizing action of etomidate and propofol apparently in full (Table 2 ; Jurd et al. 2003) and of enflurane, isoflurane and halothane in part (Jurd et al. 2003; Lambert et al. 2005; Liao et al. 2005) . In addition, they mediate part of the hypnotic action of etomidate and propofol (Jurd et al. 2003) but apparently not of the volatile anaesthetics (Jurd et al. 2003; . In contrast, the hypnotic action of etomidate is mediated by β 2 -containing GABA A receptors (Reynolds et al. 2003) . Further studies have revealed that the respiratory depressant action of etomidate and propofol is also mediated by β 3 -containing GABA A receptors, whereas the heart-rate depressant action and, to a large part, the hypothermic action of etomidate and propofol are mediated by other targets (Zeller et al. 2005; Cirone et al. 2004 ). Thus, a β 3 -selective agent would be predicted to be immobilizing and respiratory depressant but would largely lack the heart-rate depressant and hypothermic actions of etomidate and propofol. The analysis of α subunits involved in mediating the actions of general anaesthetics is expected to result in further insights into the contribution of GABA A receptors to anaesthesia. Mutations in α subunits have been identified in recombinant studies that render α x β x γ 2 GABA A receptors insensitive to specific volatile anaesthetics but not to etomidate or propofol (Mihic et al. 1997; Krasowski et al. 1998) . Studies with knock-in mice carrying these mutations are expected to yield information as to the contribution of individual GABA A receptors subtypes and the GABA A receptor family as a whole to the action of volatile general anaesthetics.
GABA A receptors controlling postnatal development
Apart from its trophic role in embryonal development (Represa and Ben-Ari 2005) , GABA is a major determinant for postnatal developmental plasticity; this has been investigated in various sensory systems. For instance, in the rodent somatosensory system, axons from each whisker form a somatotopic map in the cortex, known as the barrel map. During a critical period of neonatal development, this barrel map is fine-tuned in response to sensory experience based on a variety of synaptic mechanisms involving not only excitatory, but also inhibitory circuits (Foeller and Feldmann 2004) . The role of inhibitory circuits in synaptic reorganization is similarly apparent in the auditory system. Recent work has revealed a dramatic remodelling of inhibitory synapses shortly after the onset of hearing (aural dominance bands). The restructuring relies on both spontaneous and sensory-evoked neural activity (Kandler 2004 ). In the postnatal visual system, the role of GABA has been investigated in detail.
In the visual system, developmental plasticity is most apparent in the formation of ocular dominance columns in layer IV of the primary visual cortex. Cortical territories receiving neuronal input from one eye alternate with territories from the other eye. Initially, at birth, the thalamic inputs from both eyes to the visual cortex are totally overlapping (Ferster 2004) . The separation of the visual inputs into ocular dominance columns only arises in the subsequent phase of remodeling. This process is sensitive to light as shown by classical work on the influence of monocular deprivation on ocular dominance plasticity (Wiesel and Hubel 1963) . After the closure of one eye during a critical period of early postnatal life, the input from the open eye subsequently has a larger cortical territory than the input from the deprived eye. Critical period plasticity is best viewed as a continuum of local circuit computations that result in a structural rewiring of thalamic afferents (Hensch 2005) .
The mechanism of visual cortical plasticity was analyzed in detail with regard to the contribution of intracortical GABAergic transmission. GABAergic transmission was modulated locally by infusion of the benzodiazepine agonist diazepam or the inverse agonist DMCM. Following chronic infusion of diazepam into the striate cortex (starting at postnatal days 14-17), the spacing of the ocular columns was widened, whereas infusion of DMCM reduced the spacing (Hensch and Stryker 2004) . Visual responsiveness remained undisturbed under these conditions (Hensch and Stryker 2004) . Thus, intracortical GABA interneurons shape the geometry of the incoming thalamic arbours. In addition, the degree of GABAergic inhibition has been found to be a key determinant for the onset of critical period plasticity. The enhancement of GABA transmission by diazepam has long been known to induce the premature onset of the critical period (Fagiolini and Hensch 2000) . It has now been found that only circuits containing α 1 GABA A receptors drive cortical plasticity, whereas α 2 -enriched connections separately regulate neuronal firing (Fagiolini et al. 2004 ). These results are based on the use of knock-in mice in which the respective individual α-subunit had been rendered diazepam-insensitive by a point mutation (Rudolph et al. 1999; Löw et al. 2000) . These recent findings therefore present a cellular and molecular basis for critical period plasticity in the visual cortex triggered by neuronal inhibition (Fagiolini et al. 2004; Ferster 2004) .
For ocular stripes to form postnatally, activity in nearby inputs from the same eye are considered to cooperate with each other as cluster of cortical cells in their bid to take over cortical territory (Ferster 2004) . By lateral GABAergic inhibitory connections, activity in more distant cells must be "anti-correlated". Inputs from the same eye are therefore suppressed in their bid to take over the adjacent territories. The pattern of ocular dominance columns thus arises during the segregation of eye-specific inputs to the visual cortex in a self-organizing process. The cortex itself, through a specific type of GABAergic interneuron, plays a central role in organizing this pattern (Ferster 2004) . The special developmental function of neocortical α 1 GABA A receptors suggests that constraints should be placed on drugs designated for use in human infants (Fagiolini et al. 2004 ).
